1
|
Mustafina M, Silantyev A, Krasovskiy S, Chernyak A, Naumenko Z, Suvorov A, Gognieva D, Abdullaev M, Bektimirova A, Bykova A, Dergacheva V, Betelin V, Kopylov P. Exhaled breath analysis in adult patients with cystic fibrosis by real-time proton mass spectrometry. Clin Chim Acta 2024; 560:119733. [PMID: 38777246 DOI: 10.1016/j.cca.2024.119733] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2024] [Revised: 03/07/2024] [Accepted: 05/14/2024] [Indexed: 05/25/2024]
Abstract
BACKGROUND Proton-transfer reaction time-of-flight mass spectrometry (PTR-TOF-MS) is a promising tool for a rapid online determination of exhaled volatile organic compounds (eVOCs) profiles in patients with cystic fibrosis (CF). OBJECTIVE To detect VOC breath signatures specific to adult patients with CF compared with controls using PTR-TOF-MS. METHODS 102 CF patients (54 M/48, mean age 25.6 ± 7.8 yrs) and 97 healthy controls (56 M/41F, mean age 25.8 ± 6.0 yrs) were examined. Samples from normal quiet breathing and forced expiratory maneuvers were analyzed with PTR-TOF-MS (Ionicon, Austria) to obtain VOC profiles listed as ions at various mass-to-charge ratios (m/z). RESULTS PTR-TOF-MS analysis was able to detect 167 features in exhaled breath from CF patients and healthy controls. According to cluster analysis and LASSO regression, patients with CF and controls were separated. The most significant VOCs for CF were indole, phenol, dimethyl sulfide, and not indicated: m/z = 297.0720 ([C12H13N2O7 and C17H13O5]H + ), m/z = 281.0534 ([C19H7NO2, C12H11NO7 and C16H9O5]H + ) during five-fold cross-validation both in forced expiratory maneuver and in normal quiet breathing. CONCLUSION PTR-TOF-MS is a promising method for determining the molecular composition of exhaled air specific to CF.
Collapse
Affiliation(s)
- Malika Mustafina
- Department of Cardiology, Functional and Ultrasound Diagnostics, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia; Pulmonology Research Institute Under Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia; Research Institute for Systemic Analysis of the Russian Academy of Sciences, 117218 Moscow, Russia.
| | - Artemiy Silantyev
- World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia
| | - Stanislav Krasovskiy
- Pulmonology Research Institute Under Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia
| | - Alexander Chernyak
- Pulmonology Research Institute Under Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia
| | - Zhanna Naumenko
- Pulmonology Research Institute Under Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia
| | - Aleksandr Suvorov
- World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia
| | - Daria Gognieva
- World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia; Research Institute for Systemic Analysis of the Russian Academy of Sciences, 117218 Moscow, Russia
| | - Magomed Abdullaev
- World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia; Research Institute for Systemic Analysis of the Russian Academy of Sciences, 117218 Moscow, Russia
| | - Alina Bektimirova
- World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia
| | - Aleksandra Bykova
- Department of Cardiology, Functional and Ultrasound Diagnostics, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia; Research Institute for Systemic Analysis of the Russian Academy of Sciences, 117218 Moscow, Russia
| | - Vasilisa Dergacheva
- World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia
| | - Vladimir Betelin
- Research Institute for Systemic Analysis of the Russian Academy of Sciences, 117218 Moscow, Russia
| | - Philipp Kopylov
- World-Class Research Center "Digital Biodesign and Personalized Healthcare", I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia; Research Institute for Systemic Analysis of the Russian Academy of Sciences, 117218 Moscow, Russia
| |
Collapse
|
2
|
Żuchowska K, Filipiak W. Modern approaches for detection of volatile organic compounds in metabolic studies focusing on pathogenic bacteria: Current state of the art. J Pharm Anal 2024; 14:100898. [PMID: 38634063 PMCID: PMC11022102 DOI: 10.1016/j.jpha.2023.11.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2023] [Revised: 10/03/2023] [Accepted: 11/15/2023] [Indexed: 04/19/2024] Open
Abstract
Pathogenic microorganisms produce numerous metabolites, including volatile organic compounds (VOCs). Monitoring these metabolites in biological matrices (e.g., urine, blood, or breath) can reveal the presence of specific microorganisms, enabling the early diagnosis of infections and the timely implementation of targeted therapy. However, complex matrices only contain trace levels of VOCs, and their constituent components can hinder determination of these compounds. Therefore, modern analytical techniques enabling the non-invasive identification and precise quantification of microbial VOCs are needed. In this paper, we discuss bacterial VOC analysis under in vitro conditions, in animal models and disease diagnosis in humans, including techniques for offline and online analysis in clinical settings. We also consider the advantages and limitations of novel microextraction techniques used to prepare biological samples for VOC analysis, in addition to reviewing current clinical studies on bacterial volatilomes that address inter-species interactions, the kinetics of VOC metabolism, and species- and drug-resistance specificity.
Collapse
Affiliation(s)
- Karolina Żuchowska
- Department of Pharmacodynamics and Molecular Pharmacology, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-089 Bydgoszcz, Poland
| | - Wojciech Filipiak
- Department of Pharmacodynamics and Molecular Pharmacology, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-089 Bydgoszcz, Poland
| |
Collapse
|
3
|
Zhang L, Lin W, Di C, Hou H, Chen H, Zhou J, Yang Q, He G. Metabolomics and Biomarkers for Paroxysmal and Persistent Atrial Fibrillation. J Am Heart Assoc 2024; 13:e032153. [PMID: 38293949 PMCID: PMC11056137 DOI: 10.1161/jaha.123.032153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/09/2023] [Accepted: 12/05/2023] [Indexed: 02/01/2024]
Abstract
BACKGROUND Atrial fibrillation (AF) is the most common type of arrhythmia worldwide and is associated with serious complications. This study investigated the metabolic biomarkers associated with AF and the differences in metabolomics and associated metabolic biomarkers between paroxysmal AF (AFPA) and persistent AF. METHODS AND RESULTS Plasma samples were prospectively collected from patients with AF and patients in sinus rhythm with negative coronary angiography. The patients were divided into 3 groups: AFPA, persistent AF, and sinus rhythm (N=54). Metabolomics (n=36) using ultra-high-performance liquid chromatography mass spectrometry was used to detect differential metabolites that were validated in a new cohort (n=18). The validated metabolites from the validation phase were further analyzed by receiver operating characteristic. Among the 36 differential metabolites detected by omics assay, 4 were successfully validated with area under the curve >0.8 (P<0.05). Bioinformatics analysis confirmed the enrichment pathways of unsaturated fatty acid biosynthesis, glyoxylate and dicarboxylate metabolism, and carbon metabolism. Arachidonic acid was a potential biomarker of AFPA, glycolic acid and L-serine were biomarkers of AFPA and persistent AF, and palmitelaidic acid was a biomarker of AFPA. CONCLUSIONS In this metabolomics study, we detected 36 differential metabolites in AF, and 4 were validated with high sensitivity and specificity. These differential metabolites are potential biomarkers for diagnosis and monitoring of disease course. This study therefore provides new insights into the precision diagnosis and management of AF.
Collapse
Affiliation(s)
- Li‐Li Zhang
- Faculty of Graduate StudiesChengde Medical University, Chengde, China, & Department of Cardiovascular Surgery & The Institute of Cardiovascular Diseases, TEDA International Cardiovascular Hospital, Tianjin University & Chinese Academy of Medical SciencesTianjinChina
- Tianjin Key Laboratory of Molecular Regulation of Cardiovascular Diseases and Translational MedicineTianjinChina
| | - Wen‐Hua Lin
- Department of Cardiology & The Institute of Cardiovascular Diseases, TEDA International Cardiovascular HospitalTianjin University & Chinese Academy of Medical ScienceTianjinChina
| | - Cheng‐Ye Di
- Department of Cardiology & The Institute of Cardiovascular Diseases, TEDA International Cardiovascular HospitalTianjin University & Chinese Academy of Medical ScienceTianjinChina
| | - Hai‐Tao Hou
- Tianjin Key Laboratory of Molecular Regulation of Cardiovascular Diseases and Translational MedicineTianjinChina
- Department of Cardiovascular Surgery & The Institute of Cardiovascular Diseases, TEDA International Cardiovascular HospitalTianjin University & Chinese Academy of Medical ScienceTianjinChina
| | - Huan‐Xin Chen
- Tianjin Key Laboratory of Molecular Regulation of Cardiovascular Diseases and Translational MedicineTianjinChina
- Department of Cardiovascular Surgery & The Institute of Cardiovascular Diseases, TEDA International Cardiovascular HospitalTianjin University & Chinese Academy of Medical ScienceTianjinChina
| | - Jie Zhou
- Tianjin Key Laboratory of Molecular Regulation of Cardiovascular Diseases and Translational MedicineTianjinChina
- Department of Cardiovascular Surgery & The Institute of Cardiovascular Diseases, TEDA International Cardiovascular HospitalTianjin University & Chinese Academy of Medical ScienceTianjinChina
| | - Qin Yang
- Tianjin Key Laboratory of Molecular Regulation of Cardiovascular Diseases and Translational MedicineTianjinChina
- Department of Cardiovascular Surgery & The Institute of Cardiovascular Diseases, TEDA International Cardiovascular HospitalTianjin University & Chinese Academy of Medical ScienceTianjinChina
| | - Guo‐Wei He
- Faculty of Graduate StudiesChengde Medical University, Chengde, China, & Department of Cardiovascular Surgery & The Institute of Cardiovascular Diseases, TEDA International Cardiovascular Hospital, Tianjin University & Chinese Academy of Medical SciencesTianjinChina
- Tianjin Key Laboratory of Molecular Regulation of Cardiovascular Diseases and Translational MedicineTianjinChina
- Department of Cardiovascular Surgery & The Institute of Cardiovascular Diseases, TEDA International Cardiovascular HospitalTianjin University & Chinese Academy of Medical ScienceTianjinChina
| |
Collapse
|
4
|
Rankin‐Turner S, Sears P, Heaney LM. Applications of ambient ionization mass spectrometry in 2022: An annual review. ANALYTICAL SCIENCE ADVANCES 2023; 4:133-153. [PMID: 38716065 PMCID: PMC10989672 DOI: 10.1002/ansa.202300004] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/07/2023] [Revised: 04/16/2023] [Accepted: 04/17/2023] [Indexed: 06/28/2024]
Abstract
The development of ambient ionization mass spectrometry (AIMS) has transformed analytical science, providing the means of performing rapid analysis of samples in their native state, both in and out of the laboratory. The capacity to eliminate sample preparation and pre-MS separation techniques, leading to true real-time analysis, has led to AIMS naturally gaining a broad interest across the scientific community. Since the introduction of the first AIMS techniques in the mid-2000s, the field has exploded with dozens of novel ion sources, an array of intriguing applications, and an evident growing interest across diverse areas of study. As the field continues to surge forward each year, ambient ionization techniques are increasingly becoming commonplace in laboratories around the world. This annual review provides an overview of AIMS techniques and applications throughout 2022, with a specific focus on some of the major fields of research, including forensic science, disease diagnostics, pharmaceuticals and food sciences. New techniques and methods are introduced, demonstrating the unwavering drive of the analytical community to further advance this exciting field and push the boundaries of what analytical chemistry can achieve.
Collapse
Affiliation(s)
- Stephanie Rankin‐Turner
- W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public HealthJohns Hopkins UniversityBaltimoreMarylandUSA
| | - Patrick Sears
- School of Chemistry and Chemical EngineeringUniversity of SurreyGuildfordUK
| | - Liam M Heaney
- School of Sport, Exercise and Health SciencesLoughborough UniversityLoughboroughUK
| |
Collapse
|
5
|
Geng X, Zhang K, Li H, Da Yong Chen D. Online mass spectrometry of exhaled breath with a modified ambient ion source. Talanta 2023; 255:124254. [PMID: 36634427 DOI: 10.1016/j.talanta.2023.124254] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2022] [Revised: 01/03/2023] [Accepted: 01/05/2023] [Indexed: 01/07/2023]
Abstract
Exhaled breath (EB) may contain metabolites that are closely related to human health conditions. Real time analysis of EB is important to study its true composition, however, it has been difficult. A robust ambient ionization mass spectrometry method using a modified direct analysis in real time (DART) ion source was developed for the online analysis of breath volatiles. The modified DART ion source can provide a confined region for direct sampling, rapid transmission and efficient ionization of exhaled breath. With different sampling methods, offline analysis and near real-time evaluation of exhaled breath were also achieved, and their unique molecular features were characterized. High resolution MS data aided the putative metabolite identification in breath samples, resulting in hundreds of volatile organic compounds being identified in the exhalome. The method was sensitive enough to be used for monitoring the breath feature changes after taking different food and over-the-counter medicine. Quantification was performed for pyridine and valeric acid with fasting and after ingesting different food. The developed method is fast, simple, versatile, and potentially useful for evaluating the true state of human exhaled breath.
Collapse
Affiliation(s)
- Xin Geng
- Jiangsu Collaborative Innovation Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, 210023, China
| | - Kai Zhang
- Department of Geriatric Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China; Department of Gastroenterology, Dongying People's Hospital, Dongying, Shandong, 257091, China
| | - Hongli Li
- Jiangsu Collaborative Innovation Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, 210023, China.
| | - David Da Yong Chen
- Jiangsu Collaborative Innovation Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, 210023, China; Department of Chemistry, University of British Columbia, Vancouver BC, V6T 1Z1, Canada.
| |
Collapse
|